Because transforming growth factor beta (TGF-β) has been shown to have a bimodal effect on mesangial cell (MC) proliferation, we studied its effect on MC apoptosis.
Methods
Cultured mouse MCs were used to evaluate the effect of TGF-β. Morphologic evaluation of MC apoptosis was performed by staining cells with H-33342 and propidium iodide. To confirm the effect of TGF-β on MC apoptosis, DNA was extracted from control and TGF-β-treated MCs and run on gel electrophoresis. We evaluated the effect of NG-nitro-L-arginine methyl ester (L-NAME), a nitric oxide (NO) synthase inhibitor, on TGF-β-induced MC apoptosis to determine the role of NO and studied the effect of sodium nitroprusside (SNP) and SNAP (S-nitroso-N-acetyl-penicillamine) on MC apoptosis to confirm the effect of NO. We examined the role of p53 by studying the effect of TGF-β on MCs derived from p53 knockout mice (p53KO-MC) as well as a normogenic strain (N-MC). We also examined the effect of TGF-β, SNP, and SNAP on apoptosis of p53 mutant (MDAMB-231) and wild-type p53 (MCF-7) breast cancer cell lines. In addition, Western blots were generated from control, TGF-β-treated, and SNAP-treated MCs and probed for the expression of p53.
Results
TGF-β promoted MC apoptosis. Moreover, TGF-β-treated MCs displayed integer multiples of 180 base pairs (ladder pattern). L-NAME inhibited TGF-β-induced MC apoptosis. Furthermore, SNP and SNAP, NO donors, promoted MC apoptosis. TGF-β also enhanced the MC expression of p53. TGF-β induced only a moderate degree of apoptosis in MCs derived from p53KO-MC when compared with N-MCs. Similarly, the TGF-β-induced apoptosis of MDAMB-231 was of a moderate degree when compared with MCF-7 cells.
Conclusions
We hypothesize that TGF-β promotes MC apoptosis through NO generation and p53-dependent and -independent pathways.
PesceCM, StrikerU, PetenE, ElliotS, StrikerGE.Glomerulosclerosis at both early and late stage is associated with cell turnover in mice transgenic for growth hormone. Lab Invest1991;65:601–605.
McKayK, StrikerL, StaufferJW, DoiT, AgodoaLY, StrikerGE.Transforming growth factor-beta: Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest1989;83:1160–1167.
5.
KanwarYS.Biophysiology of glomerular filtration and proteinuria. Lab Invest1984;51:7–21.
6.
RobertsAB, AnzanoMA, MeyersCA, WidemanJ, BlackerR, PanYE, SteinS, LehrmanSR, SmithJM, LambLC, SpornMB.Purification and properties of a type beta transforming growth factor from bovine kidney. Biochemistry1983;22:5692–5698.
7.
WakefieldLM, SmithDM, MasuiT, HarrisCC, SpornMB.Distribution and modulation of the cellular receptors for transforming growth factor-beta. J Cell Biol1987;105:965–975.
8.
BorderWA, OkudaS, LanguinoLR, RuoslathiE.Transforming growth factor-beta regulates production of proteoglycans by mesangial cells. Kidney Int1990;37:689–695.
9.
MassagueJ.The TGF-beta family of growth and differentiation factors. Cell1987;49:437–438.
10.
SpornMB, RobertsAB, WakefieldLM, AssoianRK.Transforming growth factor-beta: Biological function and chemical structure. Science1986;233:532–544.
11.
KlahrS, SchrienerG, IchikawaI.The progression of renal disease. N Engl J Med1988;318:1657–1666.
12.
IgnotzRA, MassagueJ.Cell adhesion protein receptors as targets for transforming growth factor-beta action. Cell1987;51:189–197.
13.
EdwardsDR, MurphyG, ReynoldsJJ, WhithamSE, DochertyAJ, AngelP, HeathJK.Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J1987;6:1899–1904.
14.
LawrenceWT, SpornMB, GorschbothC, NortonJA, GrotenclorstGR.The reversal of an adriamycin induced healing impairment with chemoattractants and growth factors. Ann Surg1986;203:142–147.
15.
MoralesTI, RobertsAB.Transforming growth factor beta regulates the metabolism of proteoglycans in bovine cartilage organ culture. J Biol Chem1988;263:12828–12831.
16.
BorderWA, RuoslahtiE.Transforming growth factor-beta in disease: The dark side of tissue repair. J Clin Invest1992;90:1–7.
17.
OkudaS, LanguinoLR, RuoslahtiE, BorderWA.Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. J Clin Invest1990;86:453–462.
18.
YamamotoT, NobleNA, MillerDE, BorderWA.Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int1994;45:916–927.
19.
HarrisonDJ.Cell death in the diseased glomerulus. Histopathology1988;12:679–683.
20.
ShimizuA, KitamuraH, MasudaY, IshizakiM, SugisakiY, YamanakaN.Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int1995;47:114–121.
21.
BakerAJ, MooneyA, HughesJ, LombardiD, JohnsonRJ, SavillJ.Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest1994;94:2105–2116.
22.
SinghalPC, FrankiN, KumariS, SanwalV, WagnerJD, MattanaJ.Extracellular matrix modulates mesangial cell apoptosis and mRNA expression of cathepsin B and issue transglutaminase. J Cell Biochem1998;68:22–30.
23.
SugiyamaH, KashiharaN, MakinoH, YarnasakiY, OtaZ.Apoptosis in glomerular sclerosis. Kidney Int1996;49:103–111.
FukudaK, KojiroM, ChiuJF.Induction of apoptosis by transforming growth factor-beta 1 in the rat hepatoma cell line McA-RH7777: A possible association with tissue transglutaminase expression. Hepatology1993;18:945–953.
26.
JurgenmmeierJM, SchmitCP, ViselE, HoflerP, BauerG.Transforming growth factor beta-treated normal fibroblast eliminate transformed fibroblasts by induction of apoptosis. Cancer Res1994;54:393–398.
27.
HughesDE, DaiA, TiffeeJC, LiHH, MundyGR, BoyceBF.Estrogen promotes apoptosis of murine osteoclasts mediated by TGFbeta. Nat Med1996;2:1132–1136.
28.
SinghalPC, ReddyK, DingG, KapasiA, FrankiN, RanjanR, NwakobyIE, GibbonsN.Ethanol-induced macrophage apoptosis: Role of TGF-β. J Immunol1999;162:3031–3036.
29.
DebbasM, WhiteE.Wild-type p53 mediates apoptosis by ElA which is inhibited by E1B. Genes Dev1993;7:546–554.
30.
SandauK, PfeilschifterJ, BruneB.Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. Kidney Int1997;52:378–386.
31.
ClarkeAR, PurdieCA, HarrisonDJ, MorrisRG, BirdCC, HooperML, WyllieAH.Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature1993;362:849–852.
32.
LoweSW, SchmittEM, SmithSW, OsborneBA, JacksT.p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature1993;362:847–849.
33.
WolfG, AberleS, ThaissF, NelsonPJ, KernkyAM, NeilsonEG, StahlRAK. TNF-a induces expression of the chemoattractant cytokine RANTES on cultured mouse mesangial cells. Kidney Int1993;44:795–804.
IsakaY, FujiwarY, UedaN, KanedaY, KamadaT, ImaiE.Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet derived growth factor gene into the rat kidney. J Clin Invest1993;92:2597–2601.
36.
BorderWA, OkudaS, LanguinoLR, SpornMB, RuoslahtiE.Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β1. Nature1990;346:371–374.
37.
CoimbraT, WigginsR, NohJW, MerrittS, PhanSH.Transforming growth factor-β production in anti-glomerular basement membrane disease in rabbit. Am J Pathol1991;138:223–234.
38.
OngACM, FineLG.Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: Implications for human renal disease progression. Am J Kidney Dis1994;23:205–209.
39.
PimentelJLJr, SundellCL, WangS, KoppJB, MonteroA, Martinez-MaldonadoM.Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy. Kidney Int1995;48:1233–1246.
40.
DingG, FrankiN, SinghalPC.Tubular cell senescence, expression of TGF-β, and p21 waf1/cip1 in interstitial fibrosis in aging rats. J Am Soc Nephrol1998;9:493. Abstract.
41.
ClouthierDE, CornefordSA, HammerRE.Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-β1 transgenic mice. J Clin Invest1997;100:2697–2713.
42.
LevineAJ.P53, the cellular gatekeeper for growth and division. Cell1997;88:321–331.
43.
KastanMB, ZhanQ, EI-DeiryWS, CarrierF, JacksT, WalshWV, PlunkettBS, VogelsteinB, FornaceALJr. A mammalian cell cycle check point pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell1992;71:587–597.
44.
LeeS, ElenbaasB, LevineAJ, GriffithJ.p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell1995;81:1013–1020.
45.
GraeberAJ, OsmaniaC, JackT, HousmanDE, KochCJ, LoweSW, GracciaAJ.Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature1996;379:88–91.
46.
BergmanL, KronckeK-D, SuschekC, KolbH, Kolb-BachofenV.Cytotoxic action of IL-10 against pancreatic islets is mediated via nitric oxide formation and is inhibited by L-NAME. FEBS Lett1992;299:103–106.
47.
BlancoFJ, OchsRL, SchwartzH, LotzM.Chondrocyte apoptosis induced by nitric oxide. Am J Pathol1995;146:75–85.
NitschDD, GhilardiN, MuhlH, NitschC, BruneB, PfeilschifterJ.Apoptosis and expression of inducible nitric oxide synthase are mutually exclusive in renal mesangial cells. Am J Pathol1997;150:889–900.
